Deploying Emerging Technologies to Improve Patient Care

Technological advances have progressed rapidly, expanding the tools used for monitoring and treatment of patients with head/neck cancer. As these technologies approach clinical deployment it is essential to understand their potential applications.

Emerging technological tools are capable of accomplishing new, clinically applicable tasks. It is imperative to stay apprised of the evolving landscape and be aware of pitfalls of these new tools in applications.

This session reviews the foundational principles and clinical applications of emerging technologies, including artificial intelligence, in the diagnosis and management of head and neck cancers. Learners  explore ethical, practical and implementation considerations for integrating AI and novel technologies into multidisciplinary head and neck cancer care. Learners will be able to identify application for emerging technology methods in surgery, radiation oncology and medical oncology.

 

Target Audience

This meeting was designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify applications of emerging technologies in radiation oncology, medical oncology, and surgery.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
Course opens: 
02/09/2026
Course expires: 
03/10/2026
Cost:
$0.00
Part of: 
2026 Multidisciplinary Head and Neck Cancers Symposium onDemand
Rating: 
0

All relevant relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.